Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Endocrinology 155 , 12801290 (2014)
Smart practice: test IGF-1 before and 6 weeks in
Research suggests AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat creation) without affecting blood sugar levels or growth parameters
This bypass also avoids first-pass metabolism, a process in which nutrients are partially broken down by the liver before they can be used
Severe kidney or liver disease is not an absolute contraindication, but since MB is extensively metabolized in the liver and about 40% excreted by the kidneys, patients with major organ impairment could accumulate the drug and experience heightened toxicity
When you'll upload You'll upload your documentation during onboarding, after you complete the intake form and the contraindication review, just before consent
US$ 27.82
US$ 27.83
US$ 25.82
US$ 27.13
US$ 28.94
